Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London afternoon: Stocks back on the climb

Mon, 11th Jan 2010 14:16

Leading shares, which had been surrendering early gains at the end of the morning, picked up again over the lunch time session, helped by expectations of a firm start by Wall Street.In the absence of much in the way of corporate events to attract attention, traders have been focused on broker notes. Oil company Cairn Energy remains the best performer after positive noises from Citigroup. The broker says that fast-tracking the multi-well exploration drilling programme in Greenland has made the group its preferred play on frontier exploration in 2010. Dana is its value play while Tullow could be the most exciting story over the first quarter.Miners are going well on another set of trade figures from China. Exports rose by 17.7%, but imports, largely raw materials including copper, jumped by 55%. Lonmin, Rio Tinto, Kazakhmys and Xstrata are leading the miners higher. Silver miner Fresnillo is little changed, however, after it dropped out of the race for Canadian mining company Canplats Resources.Barclays has received its third upbeat broker note in less than a week. This time it is Citigroup that reckons the bank is cheap, adding that the market is applying too low a rating to Barclays' earnings. Citigroup's target price is 413p, implying 30% upside.Property groups Land Securities and British Land are higher after the former was added to Goldman Sachs' 'conviction buy' list. Segro, which also updated on trading today, is higher after Goldman upgraded its rating on the stock to 'neutral'. Separately, Inès Reinman, Segro's head of Continental Europe, has resigned from the industrial property group barely a year she was promoted to the board. "Current trading and market conditions are in line with our expectations at the time of our Interim Management Statement issued on 5 November 2009," chief executive Ian Coull added.SABMiller is lower after it pulled out of the race to buy the Femsa stable of beer brands leaving the way clear for rival brewer Heineken.Cash strapped plumbers merchant Wolseley is to raise just under £24m from the sale of its Irish businesses. WIBHM, a company backed by private investor, is paying €26.5m for Wolseley Ireland Holdings Limited. The exceptional loss on disposal, excluding currency impacts, is expected to be around €55m (£50m).Online gaming group PartyGaming has tied up an an exclusive, five-year agreement with state-controlled Danske Spil to provide an online gaming platform for poker and casino games in Denmark. Outdoor clothing retailer Blacks Leisure said it is mulling a possible equity fundraising in the first quarter to raise between £15m and £20m depending on investor demand. It hopes to roll out new stores, having closed 87 loss-making outlets in the fourth quarter of 2009. It said trading in the ongoing stores was very healthy with like-for-like sales increasing by 12.0% in the half year ended 7 JanuaryThe US Navy has awarded defence and aerospace group Cobham a contract worth up to $11.5m for the UK group. Cobham has won the Band 5/6 TWT (Travelling-wave Tube) Replacement Module Assembly (TRMA) development contract.Stem cell therapy group ReNeuron said it is on track to start human trials of its flagship treatment ReN001 for disabled stroke patients in the first quarter of this year.EMED Mining's quest to reopen the Rio Tinto mine in Spain moved a step closer following recent court rulings deemed favourable to the company. The cases all related to objections by previous stakeholders in the mine.
More News
29 Nov 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Oct 2019 15:50

ReNeuron presents new data on CTX stem cell platform

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Wednesday that new data relating to its CTX stem cell platform was being presented at the 27th Annual Congress of the European Society of Gene and Cell Therapy in Barcelona.

Read more
23 Oct 2019 09:32

ReNeuron Shares Jump As Lead Cell Line Shows Further Potential

ReNeuron Shares Jump As Lead Cell Line Shows Further Potential

Read more
2 Oct 2019 15:15

ReNeuron Reports Mixed Results For Retinitis Pigmentosa Trial

ReNeuron Reports Mixed Results For Retinitis Pigmentosa Trial

Read more
21 Aug 2019 11:49

ReNeuron boosts scientific advisory board with three appointments

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the appointment of professor Robert MacLaren, Dr Sally Temple and Dr José-Alain Sahel to its scientific advisory board on Wednesday.

Read more
14 Aug 2019 15:35

ReNeuron's New Cardiff University Venture Gets Research Grant

(Alliance News) - ReNeuron Group PLC on Wednesday said a new venture with Cardiff University has secured a UK government grant to research and develop new treatments for hard-to-target disorders a

Read more
14 Aug 2019 11:16

ReNeuron enters grant-funded partnership with University of Cardiff

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group is partnering with the University of Cardiff under a new grant-funded collaboration utilising its exosome-based drug delivery technology platform, it announced on Wednesday.

Read more
16 Jul 2019 12:16

ReNeuron Secures Patents For Its Exosome Technology Platform

(Alliance News) - ReNeuron Group PLC on Tuesday said it has expanded its intellectual property estate via the grant of patents, covering its exosome technology platform.The cell-based said

Read more
11 Jul 2019 11:36

ReNeuron Annual Loss Narrows On Finance Income And Licence Fee

(Alliance News) - ReNeuron Group PLC on Thursday said its loss narrowed in its most recent financial year after it received an exclusivity fee and increased finance income.Shares in were at

Read more
14 Jun 2019 15:49

ReNeuron wins 'Breakthrough of the Year' at European Mediscience Awards

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group has won the 'Breakthrough of the Year' award at the 2019 European Mediscience Awards, it announced on Friday.

Read more
8 May 2019 11:19

ReNeuron Expects Annual Results In Line With Views After Progress

LONDON (Alliance News) - ReNeuron Group PLC on Wednesday said it expects its annual results to be in line with the board's expectations as it made progress on several clinical cell-based also

Read more
8 May 2019 08:53

ReNeuron advances blindness and stroke therapy candidates

(Sharecast News) - Therapeutics outfit ReNeuron continued to trade in line with expectations throughout its recently wrapped up trading year, advancing both its human retinal progenitor cell therapy candidate and its CTX cell therapy candidate.

Read more
26 Apr 2019 12:09

ReNeuron upbeat on early data from retinitis pigmentosa trials

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced updated positive preliminary data in its ongoing phase 1 and 2a clinical trial of its human retinal progenitor cell (hRPC) therapy candidate in the blindness-causing disease, retinitis pigmentosa (RP), on Friday.

Read more
26 Apr 2019 09:58

ReNeuron Reports Positive Test Results For Blindness Treatment Therapy

LONDON (Alliance News) - ReNeuron Group PLC on Friday reported positive trial results for its human retinal progenitor cell therapy candidate for treating blindness-causing disease retinitis in up

Read more
11 Apr 2019 18:24

DIRECTOR DEALINGS: ReNeuron Chair And Other Board Members Buy Shares

LONDON (Alliance News) - ReNeuron Group PLC said a number of directors purchased shares on Thursday, including Non-Executive Chair John Berriman who bought 80,000 shares at 225 pence Thursday, in

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.